Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Oregon for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Oregon only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Oregon (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Jonathan Yoken (NPI 1902804081)

Field	Value
Entity Type	Individual
Organization	Jonathan Yoken
Address	10819 Se Stark St
City	Portland
State	OR
ZIP	97216
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	July 12, 2005

Payer Source	Total Paid
Medicare	$1.5M
Medicaid	$0

Key Findings

This provider is a retina-focused ophthalmology practice whose top procedures are intravitreal drug injections and associated injection procedures; the three highest-revenue Medicare codes are J0178, J2777, and 67028, and their descriptions point to routine anti-VEGF and novel biologic intravitreal therapy administration for retinal disease. The code mix (drug codes J0178 and J2777 plus the intravitreal procedure 67028) is consistent with a clinic that primarily delivers in-office retinal injections rather than surgical retinal procedures.

Revenue is highly concentrated in a small number of drug and injection codes: the precomputed top-3 codes account for 82.4% of this provider's total Medicare revenue, led by J0178 at $924.8K (63.4% of Medicare revenue), followed by J2777 at $168.8K (11.6%) and 67028 at $109K (7.5%). This concentration indicates the practice’s financial dependence on intravitreal pharmacotherapies and associated administration fees.

The payer mix is effectively single-payer (Medicare): lifetime Medicare revenue is $1.5M while there is no Medicaid billing on file. Analysts should treat this profile as Medicare-dominant when evaluating utilization, negotiating rates, or considering network coverage impact.

Competitive standing across the provider’s top codes is mixed: J0178 ranks #924 of 3204 providers nationally (71st percentile), which represents a solid but not dominant national position for aflibercept administration; 67028 ranks #1266 of 4255 (70th percentile), also above median volume. By contrast, J2777 ranks #1419 of 2039 (30th percentile), indicating relatively lower national volume for faricimab billing, so the practice is a meaningful participant on older anti-VEGF use but a more modest user of newer faricimab therapy.

Imaging and follow-up services are relatively prominent for a retina practice: 92134 shows 1.6K claims and $53.7K revenue (3.7% of Medicare revenue) and ranks in the 95th percentile nationally as "notably above typical national volume," which supports a high-throughput OCT diagnostic workflow. Established patient exams (92014) also appear at above-median volume (561 claims, $52.7K, 87th percentile), suggesting ongoing chronic disease management and repeat visits.

Drug-code profile shows use of both standard and non-standard billing paths: J3490 (Unclassified drugs) generated $100.2K (6.9% of Medicare revenue) with 62 claims and $1,616 avg paid/claim, while J7999 (Compounded drug) produced $32.9K (2.3%) over 464 claims and ranks in the 86th percentile. The presence of material revenue in J3490 and a high-percentile rank for J7999 indicate notable use of non-standard or compounded medications alongside labeled biologics.

Operationally, injection claim counts and average payments diverge across drug codes: J0178 shows 1.4K claims at $678 avg paid/claim while J2777 shows 5.8K claims at $29 avg paid/claim. This pattern suggests differing unitization or billing granularity between the two drug codes—large claim volume for J2777 but much lower per-claim payment—an important consideration when modeling per-encounter revenue and drug utilization trends.

The provider's NPI has been enumerated since 2005-07-12 (~21 years ago), indicating long tenure in the market. Combined with $1.5M lifetime Medicare revenue and the concentrated injection-driven revenue mix, the data are consistent with an established, steady retina practice focused on outpatient pharmacologic care rather than broad multispecialty or Medicaid-serving activity.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

13 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,360	$680	$924.8K
J2777	Injection, faricimab‑svoa, 0.1 mg	5,820	$30	$168.8K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,100	$100	$109K
J3490	Unclassified drugs	60	$1,620	$100.2K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,630	$30	$53.7K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	560	$90	$52.7K
J7999	Compounded drug, not otherwise classified	460	$70	$32.9K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	80	$100	$7.9K
92235	The provider uses a special dye, fluorescein that causes the blood vessels in the one or both eyes to stand out in photographic images taken with the use of multiframe timing, or serial images, taken…	30	$120	$3K
67145	The provider prevents the detachment of the retina in the presence of small tears or thinning of the edges (lattice degeneration) by applying an intense light (such as a laser) to create scar tissue…	10	$200	$2.8K

Showing 1–10 of 13

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 13 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Oregon Distribution

Jonathan Yoken — 0 of 13 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Oregon

Full comparison — all codes billed, vs. state median

13 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	16	60	840	$680	$623.7K
J2777	30	30	10,050	$30	$527.6K
67028	23	70	580	$90	$72.3K
J3490	18	50	40	$640	$42.9K
J7999	15	50	270	$70	$23.4K
92014	28	440	110	$80	$16K
92235	25	30	60	$100	$11.1K
99214	3,002	6,070	80	$70	$10.3K
92134	21	390	80	$30	$8.1K
92004	281	330	40	$90	$4.8K

Showing 1–10 of 13

Related Providers

Other providers that share a Tax Identification Number (TIN) with Jonathan Yoken, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Eye Health Northwest, PC	OR	Ophthalmology Physician	$0	$15.7M
Stephen Davis	AR	Retina Specialist (Ophthalmology) Physician	$2.5M	$4.7K
Christopher Aderman	OR	Retina Specialist (Ophthalmology) Physician	$2.2M	$0
Elizabeth Verner-cole	OR	Retina Specialist (Ophthalmology) Physician	$1.7M	$0
Brian Chan-kai	OR	Retina Specialist (Ophthalmology) Physician	$1.3M	$0
Joseph Simonett	OR	Ophthalmology Physician	$532.6K	$0
Christopher Kirkpatrick	WI	Ophthalmology Physician	$288.6K	$0
David Sanders	OR	Ophthalmology Physician	$229.6K	$0
Jonathan Kemp	OR	Ophthalmology Physician	$221.9K	$0
Shane Kim	OR	Ophthalmology Physician	$191.1K	$0

Nearby Providers

Other providers in the same ZIP code as Jonathan Yoken, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Byram Healthcare Centers, Inc.	OR	Durable Medical Equipment & Medical Supplies	$0	$123.8M
Fora Health Inc.	OR	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$54.4M
Portland Adventist Medical Center	OR	General Acute Care Hospital	$0	$41.8M
Portland Adventist Medical Center	OR	Family Medicine Physician	$0	$12.8M
Portland Adventist Medical Center	OR	Family Medicine Physician	$0	$5.8M
Portland Adventist Medical Center	OR	Emergency Medical Services (Emergency Medicine) Physician	$0	$5M
Cep America LLC	OR	Emergency Medicine Physician	$0	$2.9M
Diagnostic Radiologists PC	OR	Diagnostic Radiology Physician	$0	$2.7M
Rsa - Portland, LLC	OR	End-Stage Renal Disease (ESRD) Treatment Clinic/Center	$0	$1.3M
Anchor Within Counseling	OR	Community/Behavioral Health Agency	$0	$951.7K

Jonathan Yoken — Billing Profile & Reimbursement Data

Sign up for Jonathan Yoken — Billing Profile & Reimbursement Data policy alerts

Jonathan Yoken — Billing Profile & Reimbursement Data

Sign up for Jonathan Yoken — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References